Clarient, a provider of anatomic pathology and molecular testing services, has appointed Raymond Land as its new senior vice president and CFO, effective June 5, 2008.

Alsius has received a three-year contract from Premier Purchasing Partners, to provide intravascular temperature management products to Premier's extensive network of hospitals. The agreement will be effective on July 1, 2008.

Haemonetics and Octapharma have signed a multi-year supply contract appointing Haemonetics as Octapharma's preferred provider of plasma collection technology in the US.

InSite Vision has signed a licensing and distribution agreement with Essex Bio-Technology, a biopharmaceutical drug development and marketing company in the People's Republic of China, for InSite's AzaSite 1%.

SRU Biosystems, a provider of highly sensitive labeled and label-free detection technologies, has received its 30th patent in the field of label-free optical biosensors and instrumentation.

FASgen Diagnostics and Tetracore have entered into a collaboration to produce cGMP Elisa and IHC tests for cancer biomarkers using FASgen's proprietary antibodies.

Patient Safety Technologies has closed on $2.485 million in equity financing in a first closing of a private placement. The proceeds will go towards further enhancing sales and marketing at its SurgiCount Medical subsidiary.

DiagnoCure Oncology Laboratories has announced that it will introduce its new Previstage GCC, a molecular diagnostic test for the staging of colorectal cancer, at the American Society of Clinical Oncology Annual Meeting on May 30-June 3, 2008 in Chicago, Illinois.

Impulse Monitoring has signed a three-year intraoperative neuromonitoring services agreement with the University of Virginia Health System, Charlottesville, Virginia.